UCMA Activators
UCMA Activators are a diverse array of chemical compounds that indirectly amplify the functional activity of UCMA through specific signaling pathways and cellular processes. Forskolin, by enhancing adenylate cyclase activity, leads to increased intracellular cAMP levels, thereby activating PKA, which could phosphorylate proteins that associate with UCMA, thus potentiating its role in cartilage biology and osteogenesis. IBMX, through inhibition of phosphodiesterases, sustains elevated levels of cAMP, indirectly maintaining PKA activation and potentially facilitating UCMA's functions within chondrocyte differentiation. PTH (1-34) and 17β-Estradiol act via their respective receptors to increase cAMP and activate estrogen receptor pathways, both of which may promote UCMA's involvement in bone remodeling and health. 1,25-Dihydroxyvitamin D3 interacts with the VDR to potentially influence UCMA-related gene transcription involved in bone homeostasisand calcium regulation. Lithium serves as a GSK-3 inhibitor, stimulating the Wnt signaling pathway and possibly augmenting UCMA's role in osteoblast differentiation. Dexamethasone, a glucocorticoid, can activate its receptor to influence genes associated with bone mineralization, which may indirectly increase UCMA activity.
Vitamin C contributes to UCMA activation by facilitating collagen synthesis, essential for osteoblast differentiation, while β-Glycerophosphate provides necessary phosphate groups for bone tissue mineralization, enhancing UCMA's role in this process. Small molecules that mimic the effects of BMP-2 can also promote UCMA activity by stimulating osteoblast differentiation and bone regeneration. Essential minerals like Magnesium and Zinc are integral to bone health; Magnesium's contribution to bone matrix structural integrity and Zinc's involvement in bone growth and remodeling both support UCMA's function in osteogenic processes, thereby enhancing its activity. Collectively, these activators work through various biochemical mechanisms to bolster UCMA's role in bone biology, emphasizing its importance in maintaining skeletal strength and integrity without necessitating upregulation of its expression or direct activation.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin is an adenylate cyclase activator, leading to increased levels of cyclic AMP (cAMP) in cells. The elevated cAMP levels can activate PKA, which may enhance the activity of UCMA by phosphorylating proteins that interact with UCMA, thus promoting its functional role in cartilage biology and osteogenesis. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective inhibitor of phosphodiesterases (PDEs) which prevents the breakdown of cAMP and cGMP, leading to their accumulation. This can indirectly boost UCMA activity by maintaining PKA activation, which is downstream of cAMP, and could support UCMA’s function related to chondrocyte differentiation and proliferation. | ||||||
Parathyroid hormone fragment (1-34) | 52232-67-4 | sc-487943 | 100 µg | $185.00 | ||
PTH (1-34), a parathyroid hormone fragment, stimulates the PTH1 receptor leading to increased intracellular cAMP levels. This promotes the UCMA activity by potentially enhancing the pathways involved in bone remodeling and mineralization where UCMA is implicated. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
17β-Estradiol can activate estrogen receptors, which may increase the expression of UCMA through ER-mediated signaling pathways. Estrogen has been shown to play a role in bone density and health, suggesting a pathway through which UCMA activity could be enhanced. | ||||||
1α,25-Dihydroxyvitamin D3 | 32222-06-3 | sc-202877B sc-202877A sc-202877C sc-202877D sc-202877 | 50 µg 1 mg 5 mg 10 mg 100 µg | $220.00 $645.00 $1000.00 $1500.00 $440.00 | 32 | |
1,25-Dihydroxyvitamin D3, the active form of vitamin D, binds to the vitamin D receptor (VDR) and may enhance UCMA activity by influencing the gene transcription involved in bone homeostasis and calcium regulation. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium is a GSK-3 inhibitor, which can lead to the activation of Wnt signaling pathway. Although Wnt proteins themselves are not included, lithium's effect on the pathway can potentially enhance UCMA activity linked to osteoblast differentiation and bone formation. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone is a glucocorticoid that can activate glucocorticoid receptors, potentially increasing UCMA activity by affecting the genes involved in osteoblast differentiation and bone mineralization. | ||||||
L-Ascorbic acid, free acid | 50-81-7 | sc-202686 | 100 g | $46.00 | 5 | |
L-Ascorbic acid, or vitamin C, is essential for collagen synthesis and can enhance UCMA activity by promoting collagen maturation and osteoblast differentiation, both processes where UCMA is involved. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Zinc is a trace element important for bone health and can enhance UCMA activity by its role in bone growth and remodeling, as well as by supporting osteoblast differentiation and function. | ||||||